Alpha Crest Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Alpha Crest Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $66,914 - $112,056	-483 Reduced 8.71%	5,061 $1.01 Million
Q2 2022 Aug 11, 2022	BUY	$120.42 - $169.29 $214,468 - $301,505	1,781 Added 47.33%	5,544 $809,000
Q1 2022 May 12, 2022	BUY	$127.18 - $173.91 $123,873 - $169,388	974 Added 34.92%	3,763 $614,000
Q4 2021 Feb 09, 2022	SELL	$159.56 - $209.29 $338,107 - $443,485	-2,119 Reduced 43.17%	2,789 $473,000
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $385,502 - $471,754	2,271 Added 86.12%	4,908 $927,000
Q2 2021 Aug 12, 2021	SELL	$128.63 - $176.89 $37,817 - $52,005	-294 Reduced 10.03%	2,637 $447,000
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $693,379 - $960,497	-5,467 Reduced 65.1%	2,931 $414,000
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $1.03 Million - $1.23 Million	8,398 New	8,398 $1.09 Million
Q3 2020 Nov 12, 2020	SELL	$121.19 - $165.49 $172,210 - $235,161	-1,421 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$104.21 - $156.44 $186,431 - $279,871	-1,789 Reduced 55.73%	1,421 $210,000
Q1 2020 May 13, 2020	SELL	$93.12 - $133.99 $428,165 - $616,086	-4,598 Reduced 58.89%	3,210 $349,000
Q4 2019 Feb 12, 2020	SELL	$74.51 - $124.23 $1.39 Million - $2.31 Million	-18,600 Reduced 70.43%	7,808 $899,000
Q3 2019 Nov 12, 2019	BUY	$70.9 - $87.82 $1.87 Million - $2.32 Million	26,408 New	26,408 $2.12 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.